Semaglutide
A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 572
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.